
|Articles|March 1, 2003
- Volume 0 0
Infant Colic Does Not Have Lasting Effects on Mothers' Mental Health
Advertisement
Infant colic tends to resolve by 3 months of age and has little lasting effect on mothers? mental health, according to a recent article in the Archives of Pediatrics & Adolescent Medicine. Among 547 mother?baby pairs, 131 had colic at 6 weeks of age, but only 18 of these (13.7%) still had colic at 3 months. No significant changes in anxiety and depression scores from week 1 to 6 months postpartum were found when comparing mothers whose infants had colic versus those whose infants were not colicky.
Articles in this issue
over 23 years ago
Compounding a hydroxyurea liquidover 23 years ago
Does "HC" mean "hydrophilic cream"?over 23 years ago
A Vision for Pharmacy and How to Get There?Part 1over 23 years ago
Humira (adalimumab, D2E7)over 23 years ago
Drug Diversion Versus Pain Management?Part 1over 23 years ago
Pharmacy Pays Dearly After Misleading Courtover 23 years ago
Becoming a Culturally Competent Pharmacistover 23 years ago
Is There a Vaccine in Your Future?over 23 years ago
Growing Professionally with a MentorAdvertisement
Related to this article

Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.

Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.

A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.

Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.

Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.

Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.

Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
5

